Postnatal Expansion of the Pancreatic β-Cell Mass Is Dependent on Survivin
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes results from a deficiency of functional β-cells due to both an increase in β-cell death and an inhibition of β-cell replication. The molecular mechanisms responsible for these effects in susceptible individuals are mostly unknown. The objective of this study was to determine whether a gene critical for cell division and cell survival in cancer cells, survivin, might also be important for β-cells. RESEARCH DESIGN AND METHODS—We generated mice harboring a conditional deletion of survivin in pancreatic endocrine cells using mice with a Pax-6-Cre transgene promoter construct driving tissue-specific expression of Cre-recombinase in these cells. We performed metabolic studies and immunohistochemical analyses to determine the effects of a mono- and biallelic deletion of survivin. RESULTS—Selective deletion of survivin in pancreatic endocrine cells in the mouse had no discernible effects during embryogenesis but was associated with striking decreases in β-cell number after birth, leading to hyperglycemia and early-onset diabetes by 4 weeks of age. Serum insulin levels were significantly decreased in animals lacking endocrine cell survivin, with relative stability of other hormones. Exogenous expression of survivin in mature β-cells lacking endogenous survivin completely rescued the hyperglycemic phenotype and the decrease in β-cell mass, confirming the specificity of the survivin effect in these cells. CONCLUSIONS—Our findings implicate survivin in the maintenance of β-cell mass through both replication and antiapoptotic mechanisms. Given the widespread involvement of survivin in cancer, a novel role for survivin may well be exploited in β-cell regulation in diseased states, such as diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![FIG. 4. Loss of islet cell mass and nuclear abnormalities in survivin-deficient mice. A: Expansion of the endocrine cell mass after birth. Pancreatic tissue was isolated from age-matched animals at the indicated times. The mean (± SD) islet cell mass of control (▪, n = 8 [P0], 3 [P7], 5 [P14], 4 [P21], and 4 [8W]) and survivin-deficient (□, n = 7 [P0], 3 [P7], 5 [P14], 4 [P21], and 4 [8W]) tissues was calculated by point morphometry. *Significant (P < 0.001) difference. B: β-Cell size differences in affected animals. Pancreatic tissue isolated from animals at the indicated times was stained with H-E and visualized by light microscopy. Mutant β-cells with enlarged nuclei are indicated by arrows. Bars = 20 μm. C: Nuclear size measurements from B. ▪, control tissue (n = 5); □, survivin-deficient tissue (n = 5). *Significance at P < 0.001. (Please see http://dx.doi.org/10.2337/db08-0170 for a high-quality digital representation of this image.)](https://figures.cochat.ai/paper-figures/f3d1f316f1dc47d0826359337d483aec/postnatal-expansion-of-the-pancreatic-cell-mass-is-dependent-on-survivin-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Birc5-deficient animals progressively lose β-cell mass after 2 weeks of age, and Birc5-deficient cells exhibit dysmorphic nuclei, consistent with defective cell division [59].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [59]
In the citing paper
“A recent study showed a bifunctional role for Birc5 (survivin), controlling both proliferation and inhibition of apoptosis specifically in the β-cell in vivo [59].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651 · cited 1×
“p21 protein, within a family of proteins that also includes p27 and p57, can function to inhibit (47-49) cyclin-dependent kinases leading to a decrease in the rate of cell cycle progression.”
BackgroundThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859 · cited 1×
“RESEARCH DESIGN AND METHODS Pax6-Cre mice (also called Le-Cre) were crossed with B6;129S-Gtrosa26 mice to evaluate Cre activity (29).”
MethodStöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165 · cited 1×
“Survivin was originally discovered as a homolog to the inhibitor of apoptosis proteins in cancer cells (14).”
BackgroundSelf-citationAdult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
DNA damage-induced cell death by apoptosis
Roos, W. P., & Kaina, B. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.007 · Cited by 1,500 · cited 1×
“In addition, pancreas tissue from the Cdk4-null mice show evidence of both a decrease in -cell proliferation and an increase in apoptosis (40), the latter likely induced after activation of a cell cycle checkpoint in response to a lack of cell cycle progression (47).”
BackgroundAdvances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023 · cited 1×
“p21 protein, within a family of proteins that also includes p27 and p57, can function to inhibit (47-49) cyclin-dependent kinases leading to a decrease in the rate of cell cycle progression.”
BackgroundSurvivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 900
Self-citationCyclin-Dependent Regulation of G 1 in Mammalian Fibroblasts
Ohtsubo, M., & Roberts, J. M. (1993) · Science · doi:10.1126/science.8384376 · Cited by 756 · cited 4×
“Previously, we have shown that E2F1 binds to and activates the survivin promoter in mouse embryonic fibroblasts and is responsible, in part, for its cell-cycle dependency (46).”
BackgroundInfluentialRane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., & Altieri, D. C. (1999) · Nature Cell Biology · doi:10.1038/70242 · Cited by 600 · cited 1×
“This phenotype is similar to that described after the disruption of survivin in cultured cancer cells (35,36) and after homozygous deletion of survivin in murine embryonic cells during early embryogenesis (18).”
MethodSelf-citationAshery-Padan, R., Marquardt, T., Zhou, X., & Gruss, P. (2000) · Genes & Development · doi:10.1101/gad.184000 · Cited by 576 · cited 2×
“5-kb genomic region of the mouse Pax6 promoter that has been previously shown to initiate transcription of Pax6 in the lens and in developing pancreatic endocrine cells but not in other pancreatic cells or in the central nervous system (34).”
BackgroundAdida, C., Crotty, P., McGrath, J., Berrebi, D., Diebold, J., & Altieri, D. C. (1998) · Europe PMC (PubMed Central) · Cited by 538
Self-citationUren, A. G., Wong, L., Pakusch, M., Fowler, K. J., Burrows, F. J., Vaux, D. L., & Choo, K. H. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00769-7 · Cited by 527 · cited 3×
“This phenotype is similar to that described after the disruption of survivin in cultured cancer cells (35,36) and after homozygous deletion of survivin in murine embryonic cells during early embryogenesis (18).”
BackgroundMethodInhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice
Schimmer, A. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1918 · Cited by 512 · cited 1×
“These proteins block the function of caspase proteins in the mitochondria-dependent cell death pathway (15), protecting cells from succumbing to a cascade of cellular and molecular events that characterize apoptosis.”
Backgroundβ cell replication is the primary mechanism for maintaining postnatal β cell mass
Georgia, S. K., & Bhushan, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422098 · Cited by 506
HBXIP functions as a cofactor of survivin in apoptosis suppression
Marusawa, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg263 · Cited by 432
Apoptosis Participates in the Remodeling of the Endocrine Pancreas in the Neonatal Rat
Scaglia, L. (1997) · Endocrinology · doi:10.1210/en.138.4.1736 · Cited by 418 · cited 1×
“differentiation (neogenesis), and β-cell apoptosis (1-3); each having variable importance depending on the age of the animal and changes in the body’s metabolic demands.”
BackgroundRegulation of pancreatic beta-cell mass
Bouwens, L., & Rooman, I. (2005) · Physiological Reviews · doi:10.1152/physrev.00025.2004 · Cited by 411 · cited 1×
“5) and immediately after birth, a transient burst of replication of these -cells occurs (1,6,7) with a consequent marked increase in -cell growth (2,8).”
BackgroundTargeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27 Kip1 Activity
Tsutsui, T., Hesabi, B., Moons, D. S., Pandolfi, P. P., Hansel, K. S., Koff, A., & Kiyokawa, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7011 · Cited by 395 · cited 4×
“In addition, pancreas tissue from the Cdk4-null mice show evidence of both a decrease in -cell proliferation and an increase in apoptosis (40), the latter likely induced after activation of a cell cycle checkpoint in response to a lack of cell cycle progression (47).”
BackgroundInfluentialAn Illustrated Review of Early Pancreas Development in the Mouse
Jørgensen, M. C., Ahnfelt-Rønne, J., Hald, J., Madsen, O. D., Serup, P., & Hecksher-Sørensen, J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0016 · Cited by 374
Song, Z., Yao, X., & Wu, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300957200 · Cited by 363
Chromosomal passengers: the four-dimensional regulation of mitotic events
Vagnarelli, P., & Earnshaw, W. C. (2004) · Chromosoma · doi:10.1007/s00412-004-0307-3 · Cited by 314 · cited 1×
“This phenotype parallels that of other genetic models targeting proteins known as chromosomal passenger proteins (CPPs) (19).”
BackgroundFortugno, P., Wall, N. R., Giodini, A., O'Connor, D. S., Plescia, J., Padgett, K. M., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.575 · Cited by 307
Self-citationA switch from MafB to MafA expression accompanies differentiation to pancreatic β-cells
Nishimura, W., Kondo, T., Salameh, T., El Khattabi, I., Dodge, R., Bonner-Weir, S., & Sharma, A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.02.028 · Cited by 297
Self-citationPancreas and beta-cell development: from the actual to the possible
Murtaugh, L. C. (2007) · Development · doi:10.1242/dev.02770 · Cited by 289
The case for survivin as a regulator of microtubule dynamics and cell-death decisions
Altieri, D. C. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.015 · Cited by 284 · cited 1×
“in cancer cells, but with unknown functions in most normal cells (11-13).”
BackgroundSelf-citationThe replication of β cells in normal physiology, in disease and for therapy
Butler, P. C., Meier, J. J., Butler, A. E., & Bhushan, A. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0647 · Cited by 268
Perspective: Postnatal Pancreatic β Cell Growth
Bonner-Weir, S. (2000) · Endocrinology · doi:10.1210/endo.141.6.7567 · Cited by 247
Fukuda, S., & Pelus, L. M. (2001) · Blood · doi:10.1182/blood.v98.7.2091 · Cited by 212 · cited 2×
“Survivin is a potent inhibitor of cell death in diverse malignant tumor cell types (11) and in some normal cells, including hepatocytes (16) and bone marrow stem cells (17).”
BackgroundSurvivin splice variants regulate the balance between proliferation and cell death
Caldas, H., Jiang, Y., Holloway, M. P., Fangusaro, J., Mahotka, C., Conway, E. M., & Altura, R. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208350 · Cited by 199 · cited 1×
“different partner proteins (22–24), including its own splice forms (25), to perform these different functions.”
BackgroundSelf-citationMolecular Control of Cell Cycle Progression in the Pancreatic β-Cell
Cozar-Castellano, I., Fiaschi-Taesch, N., Bigatel, T. A., Takane, K. K., Garcia-Ocaña, A., Vasavada, R., & Stewart, A. F. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0004 · Cited by 198
Gannon, M., Tweedie Ables, E., Crawford, L., Lowe, D., Offield, M. F., Magnuson, M. A., & Wright, C. V. E. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2007.10.038 · Cited by 186
The case for Survivin as mitotic regulator
Lens, S. M., Vader, G., & Medema, R. H. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.016 · Cited by 184 · cited 1×
“This hypothesis is consistent with the data here and also with the effects observed in cancer cells; high levels of survivin found in malignant human tumor cells promote tumor cell survival, whereas low survivin levels inherent to benign tumors confer no survival advantage (13).”
ResultPancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes?
Lingohr, M. K., Buettner, R., & Rhodes, C. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02377-8 · Cited by 168
Intrinsic Regulators of Pancreatic β-Cell Proliferation
Heit, J. J., Karnik, S. K., & Kim, S. K. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104425 · Cited by 165
Aberrant Regulation of Survivin by the RB/E2F Family of Proteins
Jiang, Y., Saavedra, H. I., Holloway, M. P., Leone, G., & Altura, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404496200 · Cited by 160 · cited 1×
“Previously, we have shown that E2F1 binds to and activates the survivin promoter in mouse embryonic fibroblasts and is responsible, in part, for its cell-cycle dependency (46).”
BackgroundSelf-citationConditional inactivation of Pax6 in the pancreas causes early onset of diabetes
Ashery‐Padan, R., Zhou, X., Marquardt, T., Herrera, P. L., Toube, L., Berry, A., & Gruß, P. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.01.040 · Cited by 154 · cited 3×
“To examine the functional role of survivin in all pancreatic endocrine cells both during embryogenesis and after birth, we chose a Pax6-Cre transgene construct (also known as Le-Cre) that drives tissue-specific expression of Cre-recombinase in the cells expressing Pax6 (30).”
BackgroundKaung, H. C. (1994) · Developmental Dynamics · doi:10.1002/aja.1002000208 · Cited by 150 · cited 1×
“on postnatal β-cells, this could be due to a specific necessity for its activation during the rapid proliferative phase between the end of embryogenesis and the first 2 weeks of life (40; 41).”
BackgroundSpecifying pancreatic endocrine cell fates
Collombat, P., Hecksher‐Sørensen, J., Serup, P., & Mansouri, A. (2006) · Mechanisms of Development · doi:10.1016/j.mod.2006.05.006 · Cited by 142
Beltrami, E., Plescia, J., Wilkinson, J. C., Duckett, C. S., & Altieri, D. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309479200 · Cited by 142 · cited 1×
“These effects could be mediated through repression of p21, which might occur as a consequence of survivin-dependent repression of p53 protein (37,38).”
BackgroundSelf-citationSurvivin Enhances Aurora-B Kinase Activity and Localizes Aurora-B in Human Cells
Chen, J., Jin, S. S., Tahir, S. K., Zhang, H., Liu, X., Sarthy, A. V., McGonigal, T. P., Liu, Z., Rosenberg, S. H., & Ng, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m211119200 · Cited by 139 · cited 1×
“Survivin forms a complex with other CPPs and plays an active role in recruiting aurora kinase B to the kinetochore to ensure the proper regulation of cytokinesis (20).”
BackgroundSeparating the Anti-apoptotic and Mitotic Roles of Survivin
Colnaghi, R., Connell, C. M., Barrett, R. M. A., & Wheatley, S. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600164200 · Cited by 138
Survivin Loss in Thymocytes Triggers p53-mediated Growth Arrest and p53-independent Cell Death
Okada, H., Bakal, C., Shahinian, A., Elia, A., Wakeham, A., Suh, W.-K., Duncan, G. S., Ciofani, M., Rottapel, R., Zúñiga-Pflücker, J. C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032092 · Cited by 129 · cited 1×
“These effects could be mediated through repression of p21, which might occur as a consequence of survivin-dependent repression of p53 protein (37,38).”
BackgroundEssential Role for Survivin in Early Brain Development
Jiang, Y., de Bruin, A., Caldas, H., Fangusaro, J., Hayes, J., Conway, E. M., Robinson, M. L., & Altura, R. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1446-05.2005 · Cited by 124 · cited 3×
“Mice harboring a conditionally targeted mouse survivin gene flanked by two loxP sites (survivin) have been described previously (16,27), as have Pax6-Cre mice (30).”
BackgroundSelf-citationKaneto, H., Kajimoto, Y., Fujitani, Y., Matsuoka, T., Sakamoto, K., Matsuhisa, M., Yamasaki, Y., & Hori, M. (1999) · Diabetologia · doi:10.1007/s001250051276 · Cited by 118 · cited 1×
“p21 is expressed in both human and mouse -cells and is induced in response to -cell injury (52) and growth factors (53).”
BackgroundInsulin Stimulates Primary β-Cell Proliferation via Raf-1 Kinase
Beith, J. L., Alejandro, E. U., & Johnson, J. D. (2008) · Endocrinology · doi:10.1210/en.2007-1557 · Cited by 109
Conway, E. M., Pollefeyt, S., Steiner‐Mosonyi, M., Luo, W., Vriese, A. D., Lupu, F., Bono, F., Leducq, N., Dol, F., Schaeffer, P., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34753 · Cited by 97 · cited 2×
“Survivin is a potent inhibitor of cell death in diverse malignant tumor cell types (11) and in some normal cells, including hepatocytes (16) and bone marrow stem cells (17).”
BackgroundIslet cell neogenesis in the pancreas
Bouwens, L., & Kl�ppel, G. (1996) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00202885 · Cited by 95 · cited 1×
“5) and immediately after birth, a transient burst of replication of these -cells occurs (1,6,7) with a consequent marked increase in -cell growth (2,8).”
BackgroundCozar-Castellano, I., Weinstock, M., Haught, M., Velázquez-Garcia, S., Sipula, D., & Stewart, A. F. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0632 · Cited by 89 · cited 2×
“Functionally, islet cells lacking p21 grow faster than those with an intact p21 protein (51).”
BackgroundLens, S. M. A., Rodríguez, J. A., Vader, G., Span, S. W., Giaccone, G., & Medema, R. H. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0727 · Cited by 74 · cited 1×
“This phenotype is similar to that described after the disruption of survivin in cultured cancer cells (35,36) and after homozygous deletion of survivin in murine embryonic cells during early embryogenesis (18).”
MethodMcEvoy, R. C., & Madson, K. L. (2009) · Biology of the Neonate · doi:10.1159/000241373 · Cited by 49
Dohi, T., Salz, W., Costa, M., Ariyan, C., Basadonna, G. P., & Altieri, D. C. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400640 · Cited by 32 · cited 7×
“RIP-driven transgenic expression of survivin completely rescued the diabetic phenotype of the Pax6-Cre;survivinlox/lox mice.”
BackgroundMethodInfluentialSelf-citationActivation and Maturation of Alloreactive CD4-Independent, CD8+ Cytolytic T Cells
Lunsford, K. E., Horne, P. H., Koester, M. A., Eiring, A. M., Walker, J. P., Dziema, H., & Bumgardner, G. L. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01479.x · Cited by 25
Cited by
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Structural similarities and differences between the human and the mouse pancreas
Dolenšek, J., Rupnik, M. S., & Stožer, A. (2015) · Islets · doi:10.1080/19382014.2015.1024405 · Cited by 348
Expansion of β-cell mass in response to pregnancy
Rieck, S., & Kaestner, K. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.001 · Cited by 358
Marselli, L., Thorne, J., Dahiya, S., Sgroi, D. C., Sharma, A., Bonner-Weir, S., Marchetti, P., & Weir, G. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011499 · Cited by 313
“Survivin enhances proliferation and survival of cancer cells and seems to have similar effects upon beta-cells [50].”
Self-citationThe transcriptional response of the islet to pregnancy in mice
Rieck, S., White, P., Schug, J., Fox, A. J., Smirnova, O., Gao, N., Gupta, R. K., Wang, Z. V., Scherer, P. E., Keller, M. P., et al. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0144 · Cited by 160
“Conditional deletion of Birc5, an inhibitor of apoptosis, specifically in the endocrine pancreas, showed a severe inability to maintain normal postnatal ß-cell mass throughout adulthood in vivo (15).”
Background
Metadata
- Authors
- Jiang, Y., Nishimura, W., Devor-Henneman, D., Kusewitt, D., Wang, H., Holloway, M. P., Dohi, T., Sabo, E., Robinson, M. L., Altieri, D. C., Sharma, A., & Altura, R. A.
- Affiliations
- Nationwide Children's Hospital (US)
- Joslin Diabetes Center (US)
- The Ohio State University (US)
- Brown University (US)
- University of Massachusetts Chan Medical School (US)
- Miami University (US)
- Corresponding author
- Altura, Rachel A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-10-01
- Volume
- 57
- Issue
- 10
- Pages
- 2718-2727
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2551682
- OpenAlex
- W2116245644
- Cited by
- 38
- References
- 58
- Citations by year
- 2024: 1 · 2022: 3 · 2020: 2 · 2017: 3 · 2015: 2 · 2014: 3 · 2013: 6 · 2012: 4
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (R01HL054131, R37HL054131, HL 54131)
- National Cancer Institute (R01CA078810, CA-78810, R01CA090917, CA-90917)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK078300, DK060127, R01DK060127, 1R21-DK-078300-01)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- survivin, pancreatic beta cells, beta-cell mass, postnatal development, conditional gene deletion, type 1 diabetes, hyperglycemia, insulin deficiency, beta-cell proliferation, beta-cell apoptosis, anti-apoptotic mechanisms, pancreatic endocrine cells
- MeSH terms
- Survivin, Animals, Diabetes Mellitus, Type 1, Female, Glucagon, Immunohistochemistry, Insulin, Islets of Langerhans, Male, Mice, Inbred Strains, Mice, Transgenic, Microtubule-Associated Proteins, Repressor Proteins, Somatostatin, Gene Deletion, Insulin-Secreting Cells, Inhibitor of Apoptosis Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.